Get started
Author

Sierra R. Wilson

Observed names: S. Wilson, Sierra Wilson, Wilson, Sierra
ORCID: 0000-0002-7486-7841
Observed ORCID: 0000-0002-7486-7841
OpenAlex ID: A5036260514
A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides
2020 · Anna Wolska, Larry Lo, et al. · Science Translational Medicine · 70
Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity
2020 · Jordan A. Levine, Jung Min Han, et al. · Journal of clinical lipidology · 34
A new phenotypic classification system for dyslipidemias based on the standard lipid panel
2021 · Maureen Sampson, Rami A. Ballout, et al. · Lipids in Health and Disease · 29
PDF
Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach
2019 · Mart Reimund, Anna Wolska, et al. · Biochemical and Biophysical Research Communications · 17
Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trial
2019 · Andrew P. Demidowich, Anna Wolska, et al. · Journal of clinical lipidology · 14
The Ploidy State as a Determinant of Hepatocyte Proliferation
2023 · Sierra R. Wilson, Andrew W. Duncan · Seminars in Liver Disease · 13
PDF
Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
2023 · Alexander V. Sorokin, Christin G. Hong, et al. · JCI Insight · 13
PDF
Dysregulation of Lipid and Glucose Homeostasis in Hepatocyte-Specific SLC25A34 Knockout Mice
2022 · Nairita Roy, Frances Alencastro, et al. · American Journal Of Pathology · 13
PDF
Single-Cell DNA Sequencing Reveals Chromosomal Diversity in HCC and a Novel Model of HCC Evolution
2021 · Sierra R. Wilson, Andrew W. Duncan · Gastroenterology · 2
Diploid hepatocytes resist acetaminophen-induced liver injury through suppressed JNK signaling
2026 · Sierra R. Wilson, Evan R. Delgado, et al. · Cell Death and Disease · 1
PDF
A dual ApoC-II mimetic - ApoC-III antagonist peptide as a potential treatment for hypertriglyceridemia
2021 · A. Wolska, D. Sviridov, et al. · Atherosclerosis
Calculator for Sampson LDLC plus Lipoprotein Phenotype
2020 · Sampson, Maureen, Ballout, Rami A., et al. · NIH Office of the Director (OD) General Repository
Abstract 690: A Dual apoC-II mimetic-apoC-III Antagonist Peptide for Lowering Plasma Triglycerides
2019 · Anna Wolska, Larry Lo, et al. · Arteriosclerosis Thrombosis and Vascular Biology
Works count: 20
Citation count: 206
H-index: 8
I10-index: 8
Year
Topic
Type